Even though the incidence and prevalence of NMO/NMOSD in Sweden are in line with most reports from countries with a predominately Caucasian population, we still suspect that NMOSD in Sweden is underdiagnosed, which could be compensated by increased vigilance and routine AQP4-IgG antibody analysis. The gene discussed is AQP4; the disease is neuromyelitis optica.